128 related articles for article (PubMed ID: 31998734)
1. Quantitative Analysis of Impurities in Unfractionated Heparin of Bovine Origin.
Workman WE; Carrick KL
Front Med (Lausanne); 2019; 6():315. PubMed ID: 31998734
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and detection of N-sulfonated oversulfated chondroitin sulfate in marketplace heparin.
Mans DJ; Ye H; Dunn JD; Kolinski RE; Long DS; Phatak NL; Ghasriani H; Buhse LF; Kauffman JF; Keire DA
Anal Biochem; 2015 Dec; 490():52-4. PubMed ID: 26278168
[TBL] [Abstract][Full Text] [Related]
3. Characterization of currently marketed heparin products: key tests for quality assurance.
Keire DA; Ye H; Trehy ML; Ye W; Kolinski RE; Westenberger BJ; Buhse LF; Nasr M; Al-Hakim A
Anal Bioanal Chem; 2011 Jan; 399(2):581-91. PubMed ID: 20680615
[TBL] [Abstract][Full Text] [Related]
4. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
5. Identification of heparin samples that contain impurities or contaminants by chemometric pattern recognition analysis of proton NMR spectral data.
Zang Q; Keire DA; Buhse LF; Wood RD; Mital DP; Haque S; Srinivasan S; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Bioanal Chem; 2011 Aug; 401(3):939-55. PubMed ID: 21678118
[TBL] [Abstract][Full Text] [Related]
6. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
7. Characterization of currently marketed heparin products: key tests for LMWH quality assurance.
Ye H; Toby TK; Sommers CD; Ghasriani H; Trehy ML; Ye W; Kolinski RE; Buhse LF; Al-Hakim A; Keire DA
J Pharm Biomed Anal; 2013 Nov; 85():99-107. PubMed ID: 23917037
[TBL] [Abstract][Full Text] [Related]
8. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
[TBL] [Abstract][Full Text] [Related]
9. Molecular Weights of Bovine and Porcine Heparin Samples: Comparison of Chromatographic Methods and Results of a Collaborative Survey.
Bertini S; Risi G; Guerrini M; Carrick K; Szajek AY; Mulloy B
Molecules; 2017 Jul; 22(7):. PubMed ID: 28753946
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an ion-exchange chromatography method for heparin and its impurities in heparin products.
Thiangthum S; Vander Heyden Y; Buchberger W; Viaene J; Prutthiwanasan B; Suntornsuk L
J Sep Sci; 2014 Nov; 37(22):3195-204. PubMed ID: 25146711
[TBL] [Abstract][Full Text] [Related]
11. Heparin identification test and purity test for OSCS in heparin sodium and heparin calcium by weak anion-exchange high-performance liquid chromatography.
Hashii N; Kawasaki N; Itoh S; Qin Y; Fujita N; Hattori T; Miyata K; Bando A; Sekimoto Y; Hama T; Kashimura M; Tatsumi M; Mabuchi K; Namekawa H; Sakai T; Hirose M; Dobashi S; Shimahashi H; Koyama S; Herr SO; Kawai K; Yoden H; Yamaguchi T
Biologicals; 2010 Sep; 38(5):539-43. PubMed ID: 20452241
[TBL] [Abstract][Full Text] [Related]
12. Assay of possible economically motivated additives or native impurities levels in heparin by 1H NMR, SAX-HPLC, and anticoagulation time approaches.
Keire DA; Mans DJ; Ye H; Kolinski RE; Buhse LF
J Pharm Biomed Anal; 2010 Sep; 52(5):656-64. PubMed ID: 20233649
[TBL] [Abstract][Full Text] [Related]
13. Sensitive detection of oversulfated chondroitin sulfate in heparin sodium or crude heparin with a colorimetric microplate based assay.
Sommers CD; Mans DJ; Mecker LC; Keire DA
Anal Chem; 2011 May; 83(9):3422-30. PubMed ID: 21449571
[TBL] [Abstract][Full Text] [Related]
14. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
[TBL] [Abstract][Full Text] [Related]
15. Determination of galactosamine impurities in heparin sodium using fluorescent labeling and conventional high-performance liquid chromatography.
Itoh S; Hiruta Y; Hashii N; Fujita N; Natsuga T; Hattori T; Bando A; Sekimoto Y; Miyata K; Namekawa H; Mabuchi K; Sakai T; Shimahashi H; Kawai K; Yoden H; Koyama S; Herr SO; Natsuka S; Yamaguchi T; Kawasaki N
Biologicals; 2013 Nov; 41(6):355-63. PubMed ID: 23827519
[TBL] [Abstract][Full Text] [Related]
16. Class modeling analysis of heparin 1H NMR spectral data using the soft independent modeling of class analogy and unequal class modeling techniques.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
Anal Chem; 2011 Feb; 83(3):1030-9. PubMed ID: 21192734
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
18. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.
Beyer T; Diehl B; Randel G; Humpfer E; Schäfer H; Spraul M; Schollmayer C; Holzgrabe U
J Pharm Biomed Anal; 2008 Sep; 48(1):13-9. PubMed ID: 18678460
[TBL] [Abstract][Full Text] [Related]
19. Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency.
McEwen I; Amini A; Olofsson IM
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):65-72. PubMed ID: 20223191
[TBL] [Abstract][Full Text] [Related]
20. Crude Heparin Preparations Unveil the Presence of Structurally Diverse Oversulfated Contaminants.
Mendes A; Meneghetti MCZ; Palladino MV; Justo GZ; Sassaki GL; Fareed J; Lima MA; Nader HB
Molecules; 2019 Aug; 24(16):. PubMed ID: 31426507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
